Clinical Trial Update: Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of fish oil on non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Fish oil

Snippet

Sponsor: Johane Allard | Conditions: Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED